Method, compositions, and kits for the treatment of medical conditions

Disclosed is a use of prednisolone or prednisolone acetate and cyclosporine A in the manufacture of a medicament for the treatment of an ophthalmic disorder in a patient, wherein said prednisolone or prednisolone acetate is formulated at a concentration between 0.05% and 0.12% and said cyclosporine...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NICHOLS, M JAMES, CHAPPELL, TODD W, GRAU, DANIELS S, AUSPITZ, BENJAMIN A, JOST-PRICE, EDWARD ROYDON
Format:	Patent
Sprache:	eng
Schlagworte:	AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES FISHING FORESTRY HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF TRAPPING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is a use of prednisolone or prednisolone acetate and cyclosporine A in the manufacture of a medicament for the treatment of an ophthalmic disorder in a patient, wherein said prednisolone or prednisolone acetate is formulated at a concentration between 0.05% and 0.12% and said cyclosporine A is formulated at a concentration between 0.001% and 0.049% and wherein said composition is suitable for ophthalmic administration. Also described are methods, compositions, and kits for treating an immunoinflammatory disorder, an ophthalmic disorder, a musculoskeletal disorder or pain associated therewith, a periodontal disease, or a disease or condition associated with an increased serum CRP level.